• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

CVS No Longer sending IMS Data!





Agreed, but we live in a world at Lilly where the rule makers never have to live by their own silly rules and processes. They think up this stuff in a conference run, without any significant real life experience. It looks good on the dry erase board, but doesn't hold water in the real world. They can't see the illogic in their ideas because if doesn't fit their flawed understanding of the real world.

I believe that this mirrors what we have in our federal government right now. About as much transparency at Lilly as what's in the government.